Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism
Public ClinicalTrials.gov record NCT03827941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.
Study identification
- NCT ID
- NCT03827941
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- 1 Hz Auricular transcutaneous electrical nerve stimulation Other
- 20 Hz Auricular transcutaneous electrical nerve stimulation Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2022
- Primary completion
- Sep 27, 2027
- Completion
- Sep 27, 2027
- Last update posted
- Jul 16, 2026
2022 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MGB | Charlestown | Massachusetts | 02129 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Autism Spectrum Disorder trials
Other public records listing Autism Spectrum Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07770152: Semaglutide in Youth With Autism Spectrum Disorder Not yet recruiting
- NCT07758088: Dance, Yoga, And Mindful Movement Training For ASD Not yet recruiting
- NCT07755137: Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical Settings Not yet recruiting
- NCT07746921: Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmental Disabilities Not yet recruiting
- NCT05889273: ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) Active, not recruiting
- NCT06142955: Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03827941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2026 · Synced Jul 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03827941 live on ClinicalTrials.gov.